These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8830050)

  • 1. Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice.
    Uenaka R; Kuwajima M; Ono A; Matsuzawa Y; Hayakawa J; Inohara N; Kagawa Y; Ohta S
    J Biochem; 1996 Mar; 119(3):533-40. PubMed ID: 8830050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice.
    Masuda M; Kobayashi K; Horiuchi M; Terazono H; Yoshimura N; Saheki T
    FEBS Lett; 1997 May; 408(2):221-4. PubMed ID: 9187371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Horiuchi M; Kobayashi K; Masuda M; Terazono H; Saheki T
    Biofactors; 1999; 10(2-3):301-9. PubMed ID: 10609898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation.
    Takahashi R; Asai T; Murakami H; Murakami R; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T; Okumura K
    Hypertension; 2007 Sep; 50(3):497-502. PubMed ID: 17664396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
    Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
    FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
    Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
    J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
    Jalil MA; Horiuchi M; Wakamatsu M; Li MX; Begum L; Suzuki K; Kobayashi K; Oka T; Saheki T
    J Biochem; 2006 Feb; 139(2):263-70. PubMed ID: 16452314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mRNA molecules are induced in hypertrophied ventricles of carnitine-deficient mice and belong to a family of up-regulated gene in cells overexpressing c-erbB-2.
    Fukumaru S; Horiuchi M; Kobayashi K; Jalil MA; Iijima M; Masuda M; Begum L; Higashi M; Wakana S; Kanzaki T; Saheki T
    Biochim Biophys Acta; 2002 Sep; 1577(3):437-44. PubMed ID: 12359334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
    Nakajima T; Horiuchi M; Yamanaka H; Kizaki Z; Inoue F; Kodo N; Kinugasa A; Saheki T; Sawada T
    Pediatr Res; 1997 Jul; 42(1):108-13. PubMed ID: 9212045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
    Jalil A; Horiuchi M; Nomoto M; Kobayashi K; Saheki T
    Life Sci; 1999; 64(13):1137-44. PubMed ID: 10210276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of carnitine palmitoyltransferase II in liver, muscle, and heart of mouse strain with juvenile visceral steatosis.
    Hotta K; Kuwajima M; Ono A; Uenaka R; Nakajima H; Miyagawa J; Namba M; Hanafusa T; Horiuchi M; Nikaido H; Hayakawa J; Kono N; Saheki T; Matsuzawa Y
    Biochim Biophys Acta; 1996 Feb; 1289(1):131-5. PubMed ID: 8605222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of PDK4 in the heart muscle of JVS mice, an animal model of systemic carnitine deficiency, does not appear to reduce glucose utilization by the heart.
    Ushikai M; Horiuchi M; Kobayashi K; Matuda S; Inui A; Takeuchi T; Saheki T
    Mol Genet Metab; 2011 Mar; 102(3):349-55. PubMed ID: 21190881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Yoshida G; Horiuchi M; Kobayashi K; Jalil MD; Iijima M; Hagihara S; Nagao N; Saheki T
    In Vivo; 2000; 14(3):401-5. PubMed ID: 10904873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
    Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse.
    Lu Km; Nishimori H; Nakamura Y; Shima K; Kuwajima M
    Biochem Biophys Res Commun; 1998 Nov; 252(3):590-4. PubMed ID: 9837751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.
    Sayed-Ahmed MM; Aldelemy ML; Al-Shabanah OA; Hafez MM; Al-Hosaini KA; Al-Harbi NO; Al-Sharary SD; Al-Harbi MM
    Cardiovasc Toxicol; 2014 Sep; 14(3):232-42. PubMed ID: 24469765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperammonemia in carnitine-deficient adult JVS mice used by starvation.
    Li XX; Kobayashi K; Horiuchi M; Jalil A; Yoshida G; Saheki T
    Metab Brain Dis; 2002 Dec; 17(4):359-66. PubMed ID: 12602512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
    Abdullah Abu Musa DM; Kobayashi K; Yasuda I; Iijima M; Christoffels VM; Tomomura M; Horiuchi M; Ohnishi T; Kajihara T; Daikuhara Y; Lamers WH; Saheki T
    Mol Genet Metab; 1999 Nov; 68(3):346-56. PubMed ID: 10562461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.